MINUTES
About Minutes
Back to latest

HealthUS FDA orders new eye-risk warnings for Ozempic and Zepbound

The US Food and Drug Administration told patients and healthcare providers on Monday that GLP-1 drugs used for weight loss and diabetes may be linked to a higher risk of a serious eye condition.

drug safetyGLP-1 drugseye risk

RReuters★★★☆☆2026-11-09 15:40Original

US FDA orders new eye-risk warnings for Ozempic and Zepbound
US FDA orders new eye-risk warnings for Ozempic and ZepboundHealth